These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34449514)

  • 1. Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma.
    Setakornnukul J; Chanvimalueng W; Patumanond J; Thephamongkhol K
    Medicine (Baltimore); 2021 Aug; 100(34):e27095. PubMed ID: 34449514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Liu J; Wei C; Tang H; Liu Y; Liu W; Lin C
    Medicine (Baltimore); 2020 Jan; 99(2):e18545. PubMed ID: 31914029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Ye L; Oei RW; Kong F; Xu T; Shen C; Wang X; He X; Kong L; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1309-1317. PubMed ID: 29589142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in nasopharyngeal carcinoma: A retrospective study of 180 Taiwanese patients.
    Liao LJ; Hsu WL; Wang CT; Lo WC; Cheng PW; Shueng PW; Hsieh CH; Chiu YL; Lin YC
    Clin Otolaryngol; 2018 Apr; 43(2):463-469. PubMed ID: 28950051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
    Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations.
    Lv H; Chen X; Chen X; Li J; Lu X
    Cancer Control; 2024; 31():10732748241288106. PubMed ID: 39323032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma.
    Ou D; Wang X; Wu M; Xue F; Li Y; Hu C; He X
    Strahlenther Onkol; 2020 Mar; 196(3):252-261. PubMed ID: 31701168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study.
    Saboorifar H; Zafarani Y; Gholampour G; Roghani A; Qiu F; Dequaniter D; Yu Q
    Eur Arch Otorhinolaryngol; 2024 Aug; 281(8):4315-4324. PubMed ID: 38642085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma.
    Jin Y; Ye X; He C; Zhang B; Zhang Y
    Head Neck; 2015 Jan; 37(1):69-75. PubMed ID: 24327524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
    Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
    Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Su L; Zhang M; Zhang W; Cai C; Hong J
    Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
    Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.
    Chua ML; Tan SH; Kusumawidjaja G; Shwe MT; Cheah SL; Fong KW; Soong YL; Wee JT; Tan TW
    Eur J Cancer; 2016 Nov; 67():119-129. PubMed ID: 27640138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
    Yao JJ; Zhu FT; Dong J; Liang ZB; Yang LW; Chen SY; Zhang WJ; Lawrence WR; Zhang F; Wang SY; Sun Y; Zhou GQ
    BMC Cancer; 2019 Jan; 19(1):37. PubMed ID: 30621619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis.
    Takenaka Y; Kitamura T; Oya R; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    PLoS One; 2017; 12(7):e0181478. PubMed ID: 28715474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
    Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
    Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
    Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
    Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.
    Chang H; Gao J; Xu BQ; Guo SP; Lu RB; Li G; Huang SM; Han F; Liu ZG; Tao YL; Tu ZW; Chen C; Li XH; Xia YF
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):639-46. PubMed ID: 23910226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma.
    Tang W; Long G
    PeerJ; 2024; 12():e17573. PubMed ID: 38915379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
    Jiang Y; Qu S; Pan X; Huang S; Zhu X
    Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.